Filter
1519
Text search:
cost-effectiveness
Featured
Recommendations
131
New Publications
383
Language
Document type
No document type
828
Studies & Reports
266
Guidelines
238
Manuals
79
Strategic & Response Plan
63
Fact sheets
19
Training Material
16
Brochures
2
Situation Updates
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
Global
78
India
49
Kenya
47
Western and Central Europe
38
Uganda
34
South Africa
32
Nigeria
31
Zambia
25
Africa
24
Nepal
20
Rwanda
18
Malawi
18
Latin America and the Carribbean
18
Eastern Europe
17
Ghana
16
Tanzania
16
Ethiopia
15
Myanmar / Burma
15
Asia
15
Bangladesh
13
Sierra Leone
12
Ukraine
12
Liberia
11
Cambodia
11
Russia
11
Namibia
10
Philippines
9
Pakistan
9
Indonesia
9
Lesotho
9
East and Southern Africa
9
Mozambique
8
South–East Asia Region
8
Zimbabwe
7
Botswana
7
Syria
6
Burkina Faso
5
Senegal
5
Congo, Democratic Republic of
5
USA
5
Haiti
5
Eswatini/ Swaziland
5
West and Central Africa
5
Guinea
4
South Sudan
4
Jordan
4
Iran
4
Georgia
4
Cameroon
3
Germany
3
Thailand
3
China
3
Brazil
3
Colombia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Tajikistan
3
Vietnam
3
Mali
2
Afghanistan
2
Lebanon
2
Sudan
2
Madagascar
2
Yemen
2
Western Pacific Region
2
Albania
2
Armenia
2
Southern Africa
2
Kyrgyzstan
2
Kazakhstan
2
Japan
2
Morocco
1
Saudi Arabia
1
Togo
1
Somalia
1
Iraq
1
Turkey
1
Singapore
1
Benin
1
North Macedonia
1
Serbia
1
Croatia
1
Burundi
1
Ecuador
1
El Salvador
1
Bolivia
1
Greece
1
Sri Lanka
1
Chile
1
Other region
1
Paraguay
1
Bhutan
1
Laos
1
Estonia
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
428
Clinical Guidelines
198
Public Health
115
Women & Child Health
76
Key Resources
70
Pharmacy & Technologies
17
Capacity Building
16
Toolboxes
HIV
171
Mental Health
170
TB
124
NCDs
50
NTDs
48
COVID-19
46
Disability
45
Planetary Health
45
AMR
44
Caregiver
40
Malaria
34
Pharmacy
32
Health Financing Toolbox
27
Global Health Education
22
Conflict
19
Refugee
19
Natural Hazards
18
Rapid Response
16
Polio
11
Ebola & Marburg
8
2.0 Rapid Response
8
Cholera
7
Zika
7
Specific Hazards
2
Social Ethics
2
Audit Report
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus
...
Ethiopia has seen high economic growth over the last decade, but remains a poor country with a high burden of disease. It has made considerable health gains in recent years, mainly by having health policies that focus on extending primary healthcare, using health extension workers. It
...
Рекомендации ВОЗ по оказанию дородовой помощи для формирования положительного опыта беременности
SADC Communicable Disease Project
Component 5: Scaling-up Child and Adolescent HIV, TB and Malaria Continuum of Care and Support
DRAFT POST REGIONAL CONSENSUS AND VALIDATION MEETING Oct 2012
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
Managing possible serious bacterial infection in young infants when referral is not feasible
recommended
It provides guidance on care for use in resource-limited settings or in settings where families with sick young infants do not accept or cannot access referral care, but can be managed in outpatient settings by an appropriately trained health worker. The guideline seeks to provide programmatic guida
...
17–24 November 2015
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB